Key Insights

Highlights

Treatment Research

4 treatments under study, led by Ganmaokangning Granules

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02989012Phase 2UnknownPrimary

Phase IIaTrials of GanMaoKangNing Granules

Showing all 1 trials

Research Network

Common Treatments

  • Ganmaokangning Granules1
  • Analogous Oseltamivir Phosphate Capsules1
  • Analogous Ganmaokangning Granules1
  • Oseltamivir Phosphate1

Active Sponsors

  • Dalian Zhen-Ao Bio-Tech Co., Ltd.1

Activity Timeline